Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

The clinical use of anti-oestrogens in breast cancer therapy has traditionally been restricted to tumours that contain measurable oestrogen receptor protein. However, it is now widely recognised that the clinical response to adjuvant anti-oestrogen therapy appears to be independent of the oestrogen...

Full description

Saved in:
Bibliographic Details
Main Authors: Colletta, A. A., Wakefield, L. M., Howell, F. V., van Roozendaal, K. E., Danielpour, D., Ebbs, S. R., Sporn, M. B., Baum, M.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 1990
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971440/
https://ncbi.nlm.nih.gov/pubmed/1698443
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items